Login / Signup

Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.

Bo LianHua WeiRuiyan PanJingui SunBo ZhangJing-Liang WuXiujie LiGuixiang Tian
Published in: International journal of nanomedicine (2021)
Gal-LPs co-loaded with chemotherapeutic and antiangiogenic drugs are a promising strategy for anti-hepatoma therapy.
Keyphrases
  • drug delivery
  • cancer therapy
  • inflammatory response
  • drug release
  • anti inflammatory
  • mesenchymal stem cells